본문으로 건너뛰기
← 뒤로

Clinical development of a CDK8/19 kinase inhibitor for acute myeloid leukemia.

1/5 보강
Expert opinion on investigational drugs 📖 저널 OA 0% 2022: 0/2 OA 2025: 0/6 OA 2026: 0/16 OA 2022~2026 2026 Vol.35(4) p. 253-256 Advanced Breast Cancer Therapies
Retraction 확인
출처
PubMed DOI OpenAlex 마지막 보강 2026-04-30
OpenAlex 토픽 · Advanced Breast Cancer Therapies Acute Myeloid Leukemia Research Chronic Myeloid Leukemia Treatments

Rajendra A, Yee KWL

이 논문을 인용하기

↓ .bib ↓ .ris
APA Akhil Rajendra, Karen Wl Yee (2026). Clinical development of a CDK8/19 kinase inhibitor for acute myeloid leukemia.. Expert opinion on investigational drugs, 35(4), 253-256. https://doi.org/10.1080/13543784.2026.2656430
MLA Akhil Rajendra, et al.. "Clinical development of a CDK8/19 kinase inhibitor for acute myeloid leukemia.." Expert opinion on investigational drugs, vol. 35, no. 4, 2026, pp. 253-256.
PMID 41931045 ↗

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (1)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반